Aspartate transaminase (AST) and alanine transaminase (ALT) =<  x ULN (=<  x ULN if documented liver metastases are present)
Aspartate transaminase (AST) and alanine transaminase (ALT) =<  x ULN.
Aspartate transaminase (AST /SGOT) and alanine transaminase (ALT/SGPT) ? . x ULN.
Aspartate transaminase (AST), alanine transaminase (ALT) =<   ULN
Aspartate transaminase (AST; SGOT), alanine transaminase (ALT; SGPT) ? .  ULN, (or ?   ULN if tumor involvement (liver) is present).
Aspartate transaminase (AST) and alanine transaminase (ALT) =<  x ULN
Aspartate transaminase (AST) or alanine transaminase (ALT) ?  x ULN, unless due to organ leukemic involvement
Alanine transaminase (ALT) ?  times the ULN, unless determined to be directly due to lymphoma.
Aspartate transaminase (AST) ?  times the ULN, unless determined to be directly due to lymphoma
Aspartate transaminase (AST) =<  x ULN
Aspartate transaminase (AST) and alanine transaminase (ALT) levels ? .  ULN or AST and ALT levels ?  x ULN (for subjects with documented metastatic disease to the liver)
Alanine transaminase (ALT) =< . x ULN.
Aspartate transaminase (AST) or alanine transaminase (ALT) =<  x ULN
Alanine transaminase or aspartate transaminase ?  times the ULN
Obtained =<  days prior to registration: Aspartate transaminase (AST) AND alanine transaminase (ALT) =< . x ULN
Aspartate transaminase (AST) and alanine transaminase (ALT) ?   ULN except for patients with known liver metastases, in which case aspartate transaminase or alanime transaminase may be ? .  ULN
Aspartate transaminase (AST) =< . x ULN? alanine transaminase (ALT) =< . x ULN, except for patients with liver metastasis, who are only included if AST and ALT <  x ULN
Aspartate transaminase or alanine transaminase ? x ULN (?x ULN in the presence of hepatic metastases)
Aspartate transaminase (AST) and alanine transaminase (ALT) ? . x ULN within  days prior to the first study treatment (cycle , day ) with the following exception:\r\n* Patients with liver involvement: AST and/or ALT ?  x ULN
Obtained =<  days prior to randomization: Alanine transaminase (ALT) =< . x ULN (=<  x ULN for patients with liver involvement)
Aspartate transaminase (AST) =<  x ULN, except with liver involvement by the lymphoma who are only included if AST =<  x ULN; alanine transaminase (ALT) < . x ULN, except with liver involvement by the lymphoma who are only included if AST =<  x ULN
Liver enzymes: Aspartate transaminase (AST); Alanine transaminase (ALT) or Alkaline phosphatase (ALP) ?. x ULN (or ?. x ULN if liver involvement by primary disease);
alanine transaminase (ALT) and aspartate transaminase (AST) < . x ULN (<  x ULN if documented hepatic metastases)
Alanine transaminase =<  x ULN
Alanine transaminase (ALT) ?.  ULN, or ?  ULN if leukemic infiltration of the liver is present
Aspartate transaminase (AST) ?.  ULN, or ?  ULN if leukemic infiltration of the liver is present
Aspartate transaminase (AST)/alanine transaminase (ALT) =< . x ULN
alanine transaminase (ALT) and aspartate transaminase (AST) < . x ULN (<  x ULN if documented hepatic metastases)
Aspartate transaminase (AST) or alanine transaminase (ALT) =< . x ULN
Alanine transaminase (ALT) =<  times the ULN or aspartate transaminase (AST) =<  times the ULN; this value must be obtained within two weeks before protocol entry
Aspartate transaminase (AST) ? . x ULN
Aspartate transaminase (AST) and alanine aminotransaminase (ALT) =<  x ULN
Aspartate transaminase (AST) =<  X ULN unless due to direct lymphoma involvement, and then =<  X ULN
Aspartate transaminase (AST)/alanine transferase (ALT) < . ULN
Aspartate transaminase (AST) and/or alanine transaminase (ALT) =< . x ULN or =<  x ULN for patients with liver metastases, obtained =<  days prior to registration
Aspartate transaminase (AST) or alanine transaminase (ALT) ? . x institutional ULN. If liver function abnormalities are due to metastatic disease, patients are eligible provided the ALT and AST are <  x ULN
Serum aspartate transaminase (AST) and/or alanine transaminase (ALT) ?.ULN.
Alanine transaminase (ALT) < . times the ULN
Aspartate transaminase (AST) < . times the ULN
Aspartate transaminase (AST) at least . ULN
Alanine transaminase (ALT) at least . ULN
Alanine transaminase (ALT) or aspartate transaminase (AST) =<  x ULN (if liver metastases are present, serum transaminases =<  x ULN are permitted)
Aspartate transaminase (AST) and alanine transaminase (ALT) <= . times the ULN(or <=  times the ULN if liver metastases are present).
Within  days of enrollment: Aspartate transaminase (AST) and alanine transaminase (ALT) =< . x ULN for the institution\r\n* For patients in the metastatic cohort with documented liver or bone metastases: AST and/or ALT =< . x ULN
Aspartate transaminase (AST) and alanine transaminase (ALT) =< . x ULN
Alanine transaminase (ALT) =<  x ULN (=<  x ULN for patients with liver involvement)
Aspartate transaminase (AST) =<  x ULN
Alanine transaminase (ALT) and aspartate transaminase (AST) =< . times the ULN
Aspartate transaminase (AST) and alanine transaminase (ALT) ?   ULN (?  x ULN for subjects with liver metastases)
Aspartate transaminase (AST)/alanine transaminase (ALT) =< . x ULN; unless elevated secondary to lymphoma involvement of the liver
Adequate hepatic function (total bilirubin ? .x ULN for the institution; AST [aspartate transaminase] and ALT [alanine transaminase] ? x ULN).
Adequate hepatic function (total bilirubin ? .ULN for the institution; aspartate transaminase and alanine transaminase ? .ULN, or ? ULN if due to liver involvement by tumor; albumin ?  g/dL)
Aspartate transaminase (AST) and alanine transaminase (ALT) =< . x ULN for the institution
Aspartate transaminase (AST)/alanine transaminase (ALT) =< . x ULN
. Adequate hepatic function (total bilirubin ? . x ULN for the institution; aspartate transaminase [AST] and alanine transaminase [ALT] ? . x ULN).
Liver enzymes [aspartate transaminase (AST), alanine transaminase (ALT)] ? x ULN
Serum aspartate transaminase (AST) >.x ULN
Serum alanine transaminase (ALT) >.x ULN
Aspartate transaminase (AST) =<  x ULN
Part  only: plasma total bilirubin <= . mg/dL, alanine transaminase (ALT) and aspartate transaminase (AST) <= . X ULN.
Alanine Transaminase (ALT) and Aspartate Transaminase (AST) ? . x ULN (if liver metastases are present, then ?  x ULN is allowed)
Aspartate transaminase (AST) and alanine transaminase (ALT) ?  ULN
Aspartate transaminase (AST) or alanine transaminase (ALT) ? x ULN, unless considered due to organ leukemic involvement
Aspartate transaminase (AST) =<  x ULN
Aspartate transaminase (AST) =<  x ULN unless due to direct lymphoma involvement, and then =< x ULN
Aspartate transaminase (AST)/alanine transaminase (ALT) =< . x ULN
Serum alkaline phosphatase, aspartate transaminase (AST) and alanine transaminase (ALT) ?.  ULN;
Alanine transaminase (ALT) < . x ULN
Alanine transaminase (ALT) =<  x ULN
Aspartate transaminase (AST), alanine transferase (ALT) within institutional limits of normal or judged to be not clinically significant by the investigator
Aspartate transaminase (AST) and alanine transaminase (ALT) ? . x ULN for age
Serum aspartate transaminase (AST) and serum alanine transaminase (ALT) < . x ULN or ?  X ULN for subjects with liver metastases.
